Harrow (HROW) Amortization of Deferred Charges (2017 - 2026)

Harrow (HROW) recorded quarterly Amortization of Deferred Charges of $451000.0 in Q1 2026, up 25.98% quarter-over-quarter from $358000.0 in Q4 2025, and down 64.63% on a YoY basis from $1.3 million in Q1 2025.

Harrow (HROW) Amortization of Deferred Charges (2017 - 2026) Analysis & Trends

Harrow's Amortization of Deferred Charges history runs 10 years deep, the most recent figure standing at $451000.0 for Q1 2026.

  • In Q1 2026, Amortization of Deferred Charges fell 64.63% year-over-year to $451000.0; the TTM figure through Mar 2026 stood at $2.5 million (down 14.44% YoY), while the FY2025 annual figure was $4.0 million, down 3.69% from the prior year.
  • Amortization of Deferred Charges was $451000.0 for Q1 2026 at Harrow, up from $358000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $1.5 million in Q4 2023 to a low of $193000.0 in Q1 2022.
  • Historically, Amortization of Deferred Charges has averaged $598058.8 across 5 years, with a median of $451000.0 in 2026.
  • The sharpest annual moves came in 2023 and 2025: Amortization of Deferred Charges soared 676.14% in 2023, then slumped 70.66% in 2025.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $197000.0 in 2022, then jumped by 676.14% to $1.5 million in 2023, then decreased by 20.21% to $1.2 million in 2024, then plunged by 70.66% to $358000.0 in 2025, then gained by 25.98% to $451000.0 in 2026.
  • The last three Amortization of Deferred Charges figures came in at $451000.0 (Q1 2026), $358000.0 (Q4 2025), and $745000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Harrow 1.25 Bn 1.15 Bn 27.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 451,000.00
Mar 31, 2026 451,000.00
Dec 31, 2025 358,000.00
Dec 31, 2025 358,000.00
Sep 30, 2025 745,000.00
Sep 30, 2025 745,000.00
Jun 30, 2025 916,000.00
Jun 30, 2025 916,000.00
Mar 31, 2025 1.28 Mn
Mar 31, 2025 1.28 Mn
Dec 31, 2024 1.22 Mn
Dec 31, 2024 1.22 Mn
Sep 30, 2024 197,000.00
Sep 30, 2024 197,000.00
Jun 30, 2024 195,000.00
Jun 30, 2024 195,000.00
Mar 31, 2024 976,000.00
Mar 31, 2024 976,000.00
Dec 31, 2023 1.53 Mn
Dec 31, 2023 1.53 Mn